During the past decade, San Antonio Eye Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Antonio Eye Center" #1 sponsor was "Allergan" with 2 trials, followed by "Jaeb Center for Health Research" with 2 trials sponsored, "Peschke GmbH" with 2 trials sponsored, "Santen Inc." with 2 trials sponsored and "Aerie Pharmaceuticals" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Antonio Eye Center" #1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator, "Pediatric Eye Disease Investigator Group" with 2 trials as a collaborator, "ORA, Inc." with 1 trials as a collaborator and "Statistics & Data Corporation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "San Antonio Eye Center" are "Amblyopia" (2 trials), "Corneal Ulcer" (2 trials), "Keratitis" (2 trials), "Diabetic Retinopathy" (1 trials) and "Elevated Intraocular Pressure" (1 trials). Many other conditions were trialed in "San Antonio Eye Center" in a lesser frequency.

Most popular intervention types in "San Antonio Eye Center" are "Drug" (10 trials), "Other" (5 trials), "Combination Product" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "APP13007, 0.05%" (1 trials), "AR-13324 Ophthalmic Solution 0.02%" (1 trials), "AR-13324 Ophthalmic Solution 0.04%" (1 trials), "AR-13324 Ophthalmic Solution Placebo" (1 trials) and "Abicipar Pegol" (1 trials). Other intervention names were less common.

The vast majority of trials in "San Antonio Eye Center" are 14 trials for "All" genders.

Currently, there are NaN active trials in "San Antonio Eye Center". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in San Antonio Eye Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in San Antonio Eye Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".